Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer.

about

Expression of PIM-1 in salivary gland adenoid cystic carcinoma: Association with tumor progression and patients' prognosis.Contrast-enhanced magnetic resonance imaging with a novel nano-size contrast agent for the clinical diagnosis of patients with lung cancer.

P2860

Q49225961-153D714E-569A-45FF-98B5-D220C9FE4FBF Q55072826-F93E2F69-C633-4430-9187-FBB8C06A2C0E

P2860

Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer.

Item

http://www.wikidata.org/entity/Q39198025

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Dynamic contrast-enhanced MRI ...... th non-small-cell lung cancer.

@en

Dynamic contrast-enhanced MRI ...... th non-small-cell lung cancer.

@nl

type

Item

label

Dynamic contrast-enhanced MRI ...... th non-small-cell lung cancer.

@en

Dynamic contrast-enhanced MRI ...... th non-small-cell lung cancer.

@nl

prefLabel

Dynamic contrast-enhanced MRI ...... th non-small-cell lung cancer.

@en

Dynamic contrast-enhanced MRI ...... th non-small-cell lung cancer.

@nl

P1476

Dynamic contrast-enhanced MRI ...... th non-small-cell lung cancer.

@en

P2093

Antoine Khalil

http://www.w3.org/2001/XMLSchema#string

Benjamin Besse

http://www.w3.org/2001/XMLSchema#string

Berthold Fischer

http://www.w3.org/2001/XMLSchema#string

Daniel Christoph

http://www.w3.org/2001/XMLSchema#string

Dirk Laurent

http://www.w3.org/2001/XMLSchema#string

Heiko Krissel

http://www.w3.org/2001/XMLSchema#string

Jörg Stattaus

http://www.w3.org/2001/XMLSchema#string

Katja Seng

http://www.w3.org/2001/XMLSchema#string

Mark A Horsfield

http://www.w3.org/2001/XMLSchema#string

Thomas C Gauler

http://www.w3.org/2001/XMLSchema#string

P2860

The biology of VEGF and its receptors

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features.

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma.

Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditions

Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins

Targeting EGFR resistance networks in head and neck cancer.

P304

823-833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.13.248

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Charles Soria

Bruno Morgan

Felix Nensa

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24799063

http://www.w3.org/2001/XMLSchema#string

P921

vatalanib

biomarker

Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer.

about

P2860

P2860

Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921